著者

Teruyoshi Tanaka Rui Hironaka Takashi Fukuda Masashi Ando Norifumi Shirasaka Yoshimi Homma

出版者

Japanese Society for Food Science and Technology

雑誌

Food Science and Technology Research (ISSN:13446606)

巻号頁・発行日

pp.FSTR-D-23-00139, (Released:2023-10-23)

---

Postmenopausal women have an increased risk of developing metabolic diseases, such as osteoporosis, obesity, and diabetes. Thus, chemoprophylaxis for postmenopausal symptoms through the daily diet is critical. Vanillic acid (VA) is a phenolic compound found in the herbal medicine “Toki” (Angelica acutiloba) and the mycelium of the shiitake mushroom Lentinula edodes. VA has no affinity for estrogen receptors and may offer preventive effects against these diseases. Here, we demonstrate the metabolic effects of VA in ovariectomized mice. Ten-week-old ovariectomized mice were fed a VA-containing diet (100 mg/kg body weight/day) for 10 weeks. Dietary VA significantly prevented femoral bone mineral density loss and also reduced the increases in glucose levels and white adipose tissue weights compared with those in the control group. Furthermore, uterine enlargement was not observed because of these beneficial effects. Our findings suggest that VA has the potential to mitigate postmenopausal symptoms in ovariectomized mice without estrogenic action.

著者

Teruyoshi Tanaka Hanjun Tang Kazuya Umehara Tatsuya Moriyama Yukio Kawamura

出版者

Japanese Society for Food Science and Technology

雑誌

Food Science and Technology Research (ISSN:13446606)

巻号頁・発行日

pp.FSTR-D-22-00103, (Released:2022-11-11)

---

As the average longevity of humans increases, the number of patients with osteoporosis has also increased. Chemoprevention for osteoporosis, especially through food intake, may extend the healthy life expectancy. We previously reported that kudzu (Pueraria lobata) vine ethanol extract (PVEE) in the diet (20 mg/kg body weight/day) suppresses bone resorption and prevents bone loss in ovariectomized mice. However, experiments with lower PVEE concentrations are necessary to determine whether PVEE is a suitable functional food resource to improve osteoporosis. This study thus examined the effects of PVEE intake (2 or 5 mg/kg body weight/day, approximately 0.07 or 0.17 mg PVEE isoflavone/day/mouse) for 6 months. The dose was calculated on the basis of the recommended daily isoflavone allowance in Japan. Both 5 and 2 mg PVEE successfully prevented ovariectomy-induced bone loss in mice. These results indicated that PVEE was effective at these doses. Thus, PVEE has the potential to be a promising resource for osteoporosis-preventing functional foods.